eGnome is expanding its international market presence with the introduction of advanced third-generation NGS-based microbiome diagnostic tests. These tests offer high-precision analysis, providing comprehensive insights into the microbiome. The expansion aims to deliver cutting-edge diagnostic solutions globally, enhancing healthcare outcomes through improved microbiome understanding.